Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,124 | 169 | 99.3% |
| Education | $22.16 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $701.09 | 49 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $403.76 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $381.36 | 21 | $0 (2024) |
| QOL Medical, LLC | $297.15 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $194.29 | 12 | $0 (2024) |
| Enterra Medical, Inc. | $172.96 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $159.74 | 8 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $133.21 | 8 | $0 (2024) |
| Ardelyx, Inc. | $131.16 | 6 | $0 (2024) |
| Lilly USA, LLC | $104.47 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,860 | 98 | ABBVIE INC. ($365.65) |
| 2023 | $1,270 | 71 | ABBVIE INC. ($335.44) |
| 2022 | $17.15 | 1 | Lundbeck LLC ($17.15) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $27.87 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/22/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: EndoVenous Therapies | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: LIVER DISEASE | ||||||
| 10/29/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: GI COLON PREP | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Immunology | ||||||
| 10/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $32.35 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 252 | 269 | $59,271 | $21,006 |
| 2022 | 3 | 64 | 79 | $6,818 | $3,037 |
| 2021 | 3 | 69 | 81 | $7,188 | $3,806 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 155 | $33,635 | $12,681 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $14,276 | $4,092 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 59 | $8,732 | $3,398 | 38.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,628 | $835.74 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 38 | $3,990 | $1,968 | 49.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 15 | 15 | $1,268 | $641.41 | 50.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 13 | 26 | $1,560 | $427.94 | 27.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 43 | $4,515 | $2,718 | 60.2% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 16 | 16 | $1,353 | $723.68 | 53.5% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 11 | 22 | $1,320 | $364.10 | 27.6% |
About Amy De La Rosa, PA-C
Amy De La Rosa, PA-C is a Physician Assistant healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1972730513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy De La Rosa, PA-C has received a total of $3,146 in payments from pharmaceutical and medical device companies, with $1,860 received in 2024. These payments were reported across 170 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,124).
As a Medicare-enrolled provider, De La Rosa has provided services to 385 Medicare beneficiaries, totaling 429 services with total Medicare billing of $27,850. Data is available for 3 years (2021–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Bedford, TX
- Active Since 06/22/2009
- Last Updated 12/06/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1972730513
Products in Payments
- RINVOQ (Biological) $320.88
- XIFAXAN (Drug) $275.49
- STELARA (Biological) $258.00
- SKYRIZI (Biological) $228.60
- DUPIXENT (Biological) $194.29
- SUCRAID (Drug) $151.40
- Sucraid (Drug) $145.75
- VOQUEZNA (Drug) $133.21
- IBSRELA (Drug) $131.16
- TRULANCE (Drug) $128.27
- LINZESS (Drug) $105.35
- OMVOH (Drug) $104.47
- ENTYVIO (Biological) $102.99
- REMICADE (Biological) $87.88
- DIFICID (Drug) $70.36
- TERLIVAZ (Drug) $46.97
- IDACIO (Biological) $46.44
- CREON (Drug) $46.26
- RESMETIROM (Drug) $42.70
- EOHILIA (Drug) $36.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Bedford
Jerry John
Physician Assistant — Payments: $5,297
Michael Clark, Pa, PA
Physician Assistant — Payments: $5,108
Cory Logan, Pa-C, PA-C
Physician Assistant — Payments: $4,672
Lauren Hooper
Physician Assistant — Payments: $2,718
Lauren Edwards, Pa-C, PA-C
Physician Assistant — Payments: $2,340
Micala Abbiati, Pa-C, PA-C
Physician Assistant — Payments: $1,860